Integrating GO and KEGG terms to characterize and predict acute myeloid leukemia-related genes.
Journal:
Hematology (Amsterdam, Netherlands)
Published Date:
Oct 24, 2014
Abstract
BACKGROUND/OBJECTIVE: Acute myeloid leukemia (AML) is a progressive and malignant cancer of myelogenous blood cells, which disturbs the production of normal blood cells. Although several risk and genetic factors (AML-related genes) have been investigated, the concrete mechanism underlying the development of AML remains unclear. In view of this, it is crucial to develop an effective computational method for meaningfully characterizing AML genes and accurately predicting novel AML genes.